Lite Strategy (LITS) Change in Acquisitions & Divestments (2014 - 2024)
Lite Strategy (LITS) posted quarterly Change in Acquisitions & Divestments of $20.0 million for Q4 2024, down 41.77% year-over-year from $34.3 million in Q1 2024, and up 35.85% quarter-over-quarter from $14.7 million in Q3 2024.
Lite Strategy (LITS) Change in Acquisitions & Divestments (2014 - 2024) Analysis & Trends
Lite Strategy's Change in Acquisitions & Divestments history runs 11 years deep, the most recent figure standing at $20.0 million for Q4 2024.
- In Q4 2024, Change in Acquisitions & Divestments fell 41.77% year-over-year to $20.0 million; the TTM figure through Sep 2025 stood at $20.0 million (down 78.52% YoY), while the FY2025 annual figure was $34.6 million, down 67.74% from the prior year.
- Change in Acquisitions & Divestments for Q4 2024 stood at $20.0 million, up from $14.7 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $155.1 million in Q4 2020, with the low at $14.7 million in Q3 2024.
- The 5-year median for Change in Acquisitions & Divestments is $39.3 million (2022), against an average of $53.4 million.
- The sharpest annual moves came in 2020 and 2023: Change in Acquisitions & Divestments jumped 940.3% in 2020, then tumbled 61.15% in 2023.
- Lite Strategy's Change in Acquisitions & Divestments stood at $155.1 million in 2020, then tumbled by 54.87% to $70.0 million in 2021, then plunged by 36.75% to $44.3 million in 2022, then decreased by 22.6% to $34.3 million in 2023, then plunged by 41.77% to $20.0 million in 2024.
- Business Quant data shows LITS's Change in Acquisitions & Divestments at $20.0 million in Q4 2024, $14.7 million in Q3 2024, and $19.5 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 19.95 Mn |
| Dec 31, 2024 | 19.95 Mn |
| Sep 30, 2024 | 14.69 Mn |
| Sep 30, 2024 | 14.69 Mn |
| Jun 30, 2024 | 19.54 Mn |
| Jun 30, 2024 | 19.54 Mn |
| Mar 31, 2024 | 24.42 Mn |
| Mar 31, 2024 | 24.42 Mn |
| Dec 31, 2023 | 34.27 Mn |
| Dec 31, 2023 | 34.27 Mn |
| Sep 30, 2023 | 29.15 Mn |
| Sep 30, 2023 | 29.15 Mn |
| Jun 30, 2023 | 29.10 Mn |
| Jun 30, 2023 | 29.10 Mn |
| Mar 31, 2023 | 34.27 Mn |
| Mar 31, 2023 | 34.27 Mn |
| Dec 31, 2022 | 44.27 Mn |
| Dec 31, 2022 | 44.27 Mn |
| Sep 30, 2022 | 47.85 Mn |
| Sep 30, 2022 | 47.85 Mn |